Company: IPHYF
Filing Date: 2025-04-30
Form Type: 20-F
Source: 0001598599-25-000042
Chunk: 215

Company: Innate Pharma SA
Filing Date: 2025-04-30
Form: 20-F
Item: Item 6
Chunk 215
---
 synthetic bone graft replacing bone allo-or xenografts. Mr. Itin also served as non-executive director on the board of Kymab, Ltd, a privately held UK company from 2012 until its acquisition by Sanofi in 2021. He has a diploma in biology and holds a Ph. D. in cell biology summa cum laude from the University of Basel, Switzerland and performed post-doctoral research at the Biocenter of Basel University and at Stanford University School of Medicine, California.

B. Compensation.

Compensation of Members of the Executive and Supervisory Boards

Following the entry into force of the Sapin 2 Law (French law no. 2016-1691 of December 9, 2016), the Ordonnance no. 2019-1234 dated November 27, 2019 and the Decree no. 2019-1235 dated November 27, 2019, the payment of any variable or exceptional compensation attributed for a financial year to the Chairman of the Supervisory Board, the Chairman of the Executive Board and members of the Leadership Team, is subject to approval at the next ordinary general meeting ( ex-post vote). The payments of the below variable compensations, for the year ended December 31, 2024, will be submitted for approval to the ordinary and extraordinary shareholder meeting to be held on May 22, 2025. In addition to the ex-post vote described above, French law also requires that the compensation policy for the members of the Executive and Supervisory Board for the year ending December 31, 2025 is subject to the approval at the ordinary general meeting relating to the year ending December 31, 2024.

Compensation of Members of the Supervisory Board

Attendance Fees

The Company pays attendance fees to the members of the Supervisory Board, except for the permanent representative of Bpifrance and the Chairwoman of the Supervisory Board. At its general meeting of shareholders held on May 23, 2024, shareholders set the total attendance fees to be distributed among the members of the Supervisory Board at €300,000. The attendance fees consist of a fixed portion and a

variable portion based on attendance at meetings of the Supervisory Board and its committees. The following table shows the breakdown of the attendance fees for the year ended December 31, 2024:

                                                                                                                                                                                                            Member Role                                                                 Attendance Fee  
  Fixed Portion (annual fee)                                                                                                                                                                                Supervisory Board Member                                                    €